19 patients report seizure freedom with medical cannabis oil treatment for drug-resistant epilepsy: a case series
PurposeSeizure freedom (SF) is the primary goal of epilepsy treatment. More treatments that produce SF in drug-resistant epilepsy (DRE) are needed. Cannabis-based products for medicinal use (CBPMs) containing cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC), administered as oils, have been shown...
Saved in:
| Main Authors: | Frank Yizhao Chen, Joshua Myles Duckman, Brenden Samuel Rabinovitch, Katrin Julia Hannesson, Evan Cole Lewis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnins.2025.1570531/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of the Potential for Pharmacokinetic Interactions Between Drugs and Cannabis Products in Humans
by: Dolly Andrea Caicedo, et al.
Published: (2025-03-01) -
The impact of cannabis use on ageing and longevity: a systematic review of research insights
by: Sonam Nain, et al.
Published: (2025-07-01) -
The effects of standardized cannabis products in healthy volunteers and patients: a systematic literature review
by: Nadia A. Leen, et al.
Published: (2024-10-01) -
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy
by: Isaac Cowley, et al.
Published: (2025-04-01) -
The roles of cannabis potency and gender in cannabis dependence and anxiety in recent cannabis users with trauma exposure histories
by: T. Snooks, et al.
Published: (2025-02-01)